Autoimmunity in common variable immunodeficiency: correlation with lymphocyte phenotype in the French DEFI study.

[1]  C. Cunningham-Rundles,et al.  Complement receptor 2/CD21- human naive B cells contain mostly autoreactive unresponsive clones. , 2010, Blood.

[2]  É. Oksenhendler,et al.  B-Cell and T-Cell Phenotypes in CVID Patients Correlate with the Clinical Phenotype of the Disease , 2010, Journal of Clinical Immunology.

[3]  G. Arumugakani,et al.  Frequency of Treg Cells Is Reduced in CVID Patients with Autoimmunity and Splenomegaly and Is Associated with Expanded CD21lo B Lymphocytes , 2010, Journal of Clinical Immunology.

[4]  İ. Reisli,et al.  In vivo modulation of the expressions of Fas and CD25 by intravenous immunoglobulin in common variable immunodeficiency , 2010, Clinical and Experimental Medicine.

[5]  K. Schwarz,et al.  Circulating CD21low B cells in common variable immunodeficiency resemble tissue homing, innate-like B cells , 2009, Proceedings of the National Academy of Sciences.

[6]  E. L. Luning Prak,et al.  The ITP syndrome: pathogenic and clinical diversity. , 2009, Blood.

[7]  A. Strasser,et al.  The many roles of FAS receptor signaling in the immune system. , 2009, Immunity.

[8]  Lennart Hammarstrom,et al.  Common variable immunodeficiency disorders: division into distinct clinical phenotypes. , 2008, Blood.

[9]  A. Liston,et al.  Unravelling the association of partial T-cell immunodeficiency and immune dysregulation , 2008, Nature Reviews Immunology.

[10]  P. Lipsky,et al.  Activated memory B cell subsets correlate with disease activity in systemic lupus erythematosus: delineation by expression of CD27, IgD, and CD95. , 2008, Arthritis and rheumatism.

[11]  É. Oksenhendler,et al.  Infections in 252 patients with common variable immunodeficiency. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  C. Cunningham-Rundles.  Autoimmune Manifestations in Common Variable Immunodeficiency , 2008, Journal of Clinical Immunology.

[13]  Y. Ravindranath,et al.  Increased lymphocyte Fas expression and high incidence of common variable immunodeficiency disorder in childhood Evans' syndrome. , 2007, Clinical immunology.

[14]  C. Cunningham-Rundles,et al.  CD40 ligand and MHC class II expression are essential for human peripheral B cell tolerance , 2007, The Journal of experimental medicine.

[15]  E. Milner,et al.  A New Population of Cells Lacking Expression of CD27 Represents a Notable Component of the B Cell Memory Compartment in Systemic Lupus Erythematosus1 , 2007, The Journal of Immunology.

[16]  R. Geha,et al.  Reexamining the role of TACI coding variants in common variable immunodeficiency and selective IgA deficiency , 2007, Nature Genetics.

[17]  B. Mora,et al.  Unravelling the Complexity of T Cell Abnormalities in Common Variable Immunodeficiency1 , 2007, The Journal of Immunology.

[18]  B. Fevang,et al.  Low numbers of regulatory T cells in common variable immunodeficiency: association with chronic inflammation in vivo , 2007, Clinical and experimental immunology.

[19]  B. Fazekas de St. Groth,et al.  Severely Impaired Clonal Deletion of CD4+ T Cells in Low-Dose Irradiated Mice: Role of T Cell Antigen Receptor and IL-7 Receptor Signals1 , 2006, The Journal of Immunology.

[20]  M. van der Burg,et al.  An antibody-deficiency syndrome due to mutations in the CD19 gene. , 2006, The New England journal of medicine.

[21]  K. Warnatz,et al.  Tackling the heterogeneity of CVID , 2005, Current opinion in allergy and clinical immunology.

[22]  C. Cunningham-Rundles,et al.  Treatment and outcome of autoimmune hematologic disease in common variable immunodeficiency (CVID). , 2005, Journal of autoimmunity.

[23]  R. Geha,et al.  TACI is mutant in common variable immunodeficiency and IgA deficiency , 2005, Nature Genetics.

[24]  A. Schäffer,et al.  Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans , 2005, Nature Genetics.

[25]  C. Goodnow,et al.  Cellular and genetic mechanisms of self tolerance and autoimmunity , 2005, Nature.

[26]  C. Cunningham-Rundles,et al.  Bruton's Tyrosine Kinase Is Essential for Human B Cell Tolerance , 2004, The Journal of experimental medicine.

[27]  É. Oksenhendler,et al.  Autoimmune Thrombocytopenic Purpura and Common Variable Immunodeficiency: Analysis of 21 Cases and Review of the Literature , 2004, Medicine.

[28]  Brigitta Stockinger,et al.  T Cell Regulation as a Side Effect of Homeostasis and Competition , 2003, The Journal of experimental medicine.

[29]  A. Schäffer,et al.  Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency , 2003, Nature Immunology.

[30]  J. Breuss,et al.  Genetic analysis of autoantibodies in idiopathic thrombocytopenic purpura reveals evidence of clonal expansion and somatic mutation. , 2002, Blood.

[31]  A. Denz,et al.  Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease. , 2002, Blood.

[32]  K. Becker,et al.  Enhanced T cell apoptosis in common variable immunodeficiency: negative role of the fas/fasligand system and of the Bcl‐2 family proteins and possible role of TNF‐RS , 2001, Clinical and experimental immunology.

[33]  L. Ricci-Vitiani,et al.  CD95/CD95L interactions and their role in autoimmunity , 2000, Apoptosis.

[34]  B. Falini,et al.  Defective recruitment and activation of ZAP‐70 in common variable immunodeficiency patients with T cell defects , 2000, European journal of immunology.

[35]  K. Becker,et al.  Enhanced apoptosis of T cells in common variable immunodeficiency (CVID): role of defective CD28 co‐stimulation , 2000, Clinical and experimental immunology.

[36]  L. Notarangelo,et al.  Diagnostic Criteria for Primary Immunodeficiencies , 1999 .

[37]  C. Cunningham-Rundles,et al.  Common variable immunodeficiency: clinical and immunological features of 248 patients. , 1999, Clinical immunology.

[38]  Raga,et al.  CD95 expression and function on lymphocyte subpopulations in common variable immunodeficiency (CVID); related to increased apoptosis , 1999, Clinical and experimental immunology.

[39]  M. Eibl,et al.  Activation via the antigen receptor is impaired in T cells, but not in B cells from patients with common variable immunodeficiency , 1996, European journal of immunology.

[40]  J. Farrant,et al.  Failure in antigen responses by T ceils from patients with common variable immunodeficiency (CVID) , 1994, Clinical and experimental immunology.

[41]  P. Krammer,et al.  The apoptosis-1/Fas protein in human systemic lupus erythematosus. , 1994, The Journal of clinical investigation.

[42]  W. Pruzanski,et al.  Variable region gene analysis of pathologic human autoantibodies to the related i and I red blood cell antigens. , 1991, Blood.

[43]  V. Pascual,et al.  Human Monoclonal Antibodies against Blood Group Antigens Preferentially Express a VH4‐21 Variable Region Gene‐Associated Epitope , 1991, Scandinavian journal of immunology.

[44]  C. Galambos.  Common variable immunodeficiency disorders: division into distinct clinical phenotypes , 2009 .

[45]  Eren,et al.  The EUROclass trial: defining subgroups in common variable immunodeficiency. , 2008, Blood.

[46]  Michael Schlesier,et al.  Expansion of CD19(hi)CD21(lo/neg) B cells in common variable immunodeficiency (CVID) patients with autoimmune cytopenia. , 2002, Immunobiology.

[47]  L. Notarangelo,et al.  Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). , 1999, Clinical immunology.

[48]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[49]  M. Larrieu.  Auto-immune thrombocytopenic purpura. , 1979, The Southeast Asian journal of tropical medicine and public health.